Valeant Pharmaceuticals reported $5.52B in Current Liabilities for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Amgen AMGN:US $ 14585M 1716M
Ani Pharmaceuticals ANIP:US $ 89.45M 6.69M
Aphria Inc APH:CN C$ 216.99M 75.99M
Aurora Cannabis Inc ACB:CN 116.38M 15.33M
Biogen BIIB:US $ 4211.6M 864.4M
Bristol Myers Squibb BMY:US $ 18991M 1661M
Canopy Growth Corp WEED:CN C$ 256.13M 28.2M
Catalent CTLT:US $ 1196M 56.8M
Corcept Therapeutics CORT:US $ 45.4M 4.8M
Danaher DHR:US $ 7257M 432M
Drreddys Laboratories RDY:US $ 91525M 8134M
Eli Lilly And LLY:US $ 15093.2M 3379M
Endo International Ordinary Shares ENDP:US $ 1409.21M 13.72M
Gilead Sciences GILD:US $ 10214M 509M
Gw Pharmaceuticals GWPH:US $ 160.25M 0.44M
Horizon Pharma HZNP:US $ 852.81M 78.97M
JAZZ PHA JAZZ:US $ 880.59M 128.5M
Lannett LCI:US $ 90.47M 6.66M
Nektar Therapeutics NKTR:US $ 131.02M 7.39M
Pacira Pharmaceuticals PCRX:US $ 228.69M 3.39M
Perrigo Ordinary Shares PRGO:US $ 1984.5M 537.7M
Phibro Animal Health PAHC:US $ 164.12M 4.78M
Prestige Brands PBH:US $ 125.05M 2.91M
Revance Therapeutics RVNC:US $ 58.25M 7.41M
Supernus Pharmaceuticals SUPN:US $ 283.45M 42.64M
Valeant Pharmaceuticals VRX:CN $ 5517M 619M
Vertex Pharmaceuticals VRTX:US $ 1836.45M 107.6M
Zoetis ZTS:US $ 2091M 25M